Exagen Reports Record Full-Year Revenue and Positive 2026 Guidance
XGN sits 17% above its 52-week low of $2.77.
Summary
Exagen Inc. announced record full-year 2025 revenue of $66.6 million, a 20% increase, and issued 2026 revenue guidance of $70-$73 million, alongside a strengthened cash position.
Key Events · Earnings and Guidance · XGN
-
Record Full-Year Revenue
Achieved record total revenue of $66.6 million for 2025, marking a 20% increase from the previous year.
-
Positive 2026 Guidance
Provided full-year 2026 revenue guidance in the range of $70 million to $73 million, indicating expected continued growth.
-
Strengthened Balance Sheet
Ended 2025 with $32.4 million in cash, cash equivalents, and restricted cash, bolstered by a $20 million public offering and a $25 million credit facility.
-
Operational Growth
Grew AVISE CTD test volume by over 11% and expanded its average selling price (ASP) by 7% in 2025.
Analysis · XGN · Industrial Applications And Services
Exagen Inc. reported strong financial results for the full year 2025, achieving record total revenue of $66.6 million, a 20% increase year-over-year. The company also provided optimistic revenue guidance for 2026, projecting $70 million to $73 million. While the company continues to operate at a net loss, it significantly bolstered its cash position to $32.4 million through a $20 million public offering and a $25 million credit facility, which management states positions them for cash flow positivity. This update provides a comprehensive view of the company's performance and future outlook, indicating continued growth and improved financial stability.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XGN was trading at $3.24 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $76.6M. The 52-week trading range was $2.77 to $12.23. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.